Adam J Olszewski, MD^1,2, Anna D Chorzalska, PhD^3,4*, Max Petersen^4*, Thomas A Ollila, MD^1,2, Adam Zayac, MD^2,5, Habibe Kurt, MD^6,7*, Diana O Treaba, MD^6,8*, John L Reagan, MD^2,9, Andrew Hsu, MD^2,5, Pamela C Egan, MD^1,2, James Butera, MD⁹, William Rafelson, MD, MBA², Rabin Niroula, MBBS¹⁰, John Vatkevich^11*, Jordan Robison, CRA^12*, Ilyas Sahin, MD², Chelsea D Mullins, BS^13* and Patrycja M Dubielecka, PhD^2,4

¹Brown University, Providence, RI
²Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI
³Signal Transduction Lab, Division of Hematology/Oncology, Warren Alpert Medical School at Brown University and Rhode Island Hospital, Providence, RI
⁴Signal Transduction Lab, Division of Hematology-Oncology, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, RI
⁵Department of Medicine, Alpert Medical School of Brown University, Providence, RI
⁶Department of Pathology and Laboratory Medicine, Rhode Island Hospital, Providence, RI
⁷Department of Pathology and Laboratory Medicine, Alpert Medical School of Brown University, Providence, RI
⁸Warren Alpert Medical School at Brown University, Providence, RI
⁹Alpert Medical School of Brown University, Providence, RI
¹⁰Division of Hematology/Oncology, The Warren Alpert Medical School of Brown University, Providence, RI
¹¹Lifespan Cancer Institute, Providence, RI
¹²Lifespan Oncology Clinical Research, Rhode Island Hospital, Providence, RI
¹³Adaptive Biotechnologies, Seattle, WA

Reid W Merryman, MD¹, Robert A. Redd, MS^2*, Eleanor Taranto, MD^3*, Gulrayz Ahmed, MD^4*, Erin Jeter^1*, Kristin M McHugh^1*, Jennifer R. Brown, MD, PhD^1*, Jennifer Crombie, MD^1*, Matthew S. Davids, MD¹, David C. Fisher, MD^1*, Arnold S. Freedman, MD¹, Eric Jacobsen, MD^1*, Caron Jacobson, MD, MMSc¹, Austin I. Kim, MD⁵, Ann S. LaCasce, MD, MSc¹, Benjamin L. Lampson, MD, PhD¹, Samuel Ng, MD, PhD^1*, Oreofe O. Odejide, MD, MPH¹, Parastoo B. Dahi, MD⁶, Yago Nieto, MD⁷, Robin M. Joyce, MD⁸, Yi-Bin Chen, MD⁹, Alex F. Herrera, MD¹⁰ and Philippe Armand, MD, PhD^1*

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Department of Medicine, Brigham and Women's Hospital, Boston, MA
⁴Medical College of Wisconsin, Milwaukee, WI
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY
⁷Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Hematologic Malignancy, Beth Israel Deaconess Medical Center, Boston, MA
⁹Bone Marrow Transplantation Program, Massachusetts General Hospital, Boston, MA
¹⁰Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Alex F. Herrera, MD¹, Samuel Tracy^2*, Brandon Croft^2*, Stephen Opat, FRACP, FRCPA, MBBS^3*, Jill Ray^2*, Lisa Musick, PharmD, BCPS^4*, Joseph N. Paulson^2*, Laurie H. Sehn, MD, MPH⁵ and Yanwen Jiang^2*

¹City of Hope, Duarte, CA
²Genentech, Inc., South San Francisco, CA
³Clinical Haematology, Monash Health and Monash University, Clayton, VIC, Australia
⁴Genentech, South San Francisco, CA
⁵BC Cancer Centre for Lymphoid Cancer, University of British Columbia, vancouver, BC, Canada

Joo Y Song, MD^1*, Anamarija M. Perry, MD ², Alex F. Herrera, MD³, Lu Chen, PhD^4*, Pam Skrabek, MD⁵, Michel Nasr, MD^6*, Rebecca Ottesen^7*, Janet Nikowitz^7*, Victoria Bedell^8*, Joyce Murata-Collins, PhD³, Yuping Li, PhD^1*, Christine McCarthy^7*, Raju Pillai, MD^9*, Jinhui Wang, PhD^10*, Xiwei Wu, PhD^10*, Jasmine M. Zain, MD¹¹, Leslie L. Popplewell, MD, FACP³, Larry W. Kwak, MD, PhD¹², Auayporn P. Nademanee, MD, BS¹³, Joyce Niland, PhD^7*, David W. Scott, MBChB, PhD¹⁴, Qiang Gong, PhD^1*, Wing (John) C. Chan, MD¹ and Dennis D. Weisenburger, MD³

¹Department of Pathology, City of Hope National Medical Center, Duarte, CA
²University of Michigan, Ann Arbor, MI
³City of Hope, Duarte, CA
⁴Department of Information Sciences, City of Hope, Duarte
⁵Cancercare Manitoba, Winnipeg, MB, Canada
⁶SUNY Upstate NY, Syracuse, NY
⁷City of Hope Medical Center, Duarte, CA
⁸City of Hope, Duarte
⁹Department of Pathology, City of Hope, Duarte, CA
¹⁰Department of Molecular and Cellular Biology, City of Hope National Medical Center, Duarte, CA
¹¹Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope, Duarte, CA
¹²Deputy Director, City of Hope Comprehensive Cancer Center, Duarte, CA
¹³Department of Hematology/HCT, City of Hope Nat'l. Med. Ctr., Duarte, CA
¹⁴Centre for Lymphoid Cancer, Department of Medical Oncology, BC Cancer and University of British Columbia, Vancouver, BC, Canada

Nicholas J. Boddicker, PhD¹, Pinkal Desai, MD, MPH², Mithun Vinod Shah, MD, PhD³, Vivekananda Sarangi^4*, Matthew J. Maurer, MS¹, Elliot J. Cahn^5*, Peter Martin, FRCPC, MD, MS⁶, Brian K. Link, MD⁷, Thomas E. Witzig, MD³, Andrew L. Feldman, MD⁸, Grzegorz S. Nowakowski, MD³, Thomas M. Habermann, MD³, Susan L. Slager, PhD⁹, C. Chris Huang, PhD^10*, Fadi Towfic, PhD^10*, Yan Asmann, PhD¹¹, Anita K Gandhi, PhD¹², Anne J. Novak, PhD⁵ and James R. Cerhan, MD, PhD¹

¹Department of Health Sciences Research, Mayo Clinic, Rochester, MN
²Weill Cornell Medical College, New York, NY
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester
⁵Mayo Clinic, Rochester, MN
⁶Weill Cornell Medicine, New York, NY
⁷Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
⁸Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁹Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
¹⁰Celgene Corporation, Summit, NJ
¹¹Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL
¹²Celgene Corporation, Bernardsville, NJ

Jakoba J Eertink, MSc^1*, Tim van de Brug, PhD^2*, Sanne E Wiegers, MSc^1*, Gerben J.C. Zwezerijnen, MD^3*, Elisabeth Pfaehler, MSc^4*, Pieternella J. Lugtenburg, MD, PhD⁵, Bronno van der Holt, PhD^6*, Henrica C.W. de Vet, PhD^2*, Otto S Hoekstra, MD, PhD^3*, Ronald Boellaard, PhD^3* and Josée M Zijlstra, MD, PhD^1*

¹Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
²Amsterdam UMC, Vrije Universiteit Amsterdam, department of Epidemiology and Data Science , Amsterdam Public Health research institute, Amsterdam, Netherlands
³Amsterdam UMC, Vrije Universiteit Amsterdam, department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, Netherlands
⁴Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
⁵Erasmus MC Cancer Institute, department of Hematology, Rotterdam, Netherlands
⁶Erasmus MC Cancer Institute, HOVON Data Center, department of Hematology, Rotterdam, Netherlands